Who are CRISPR Therapeutics AG's main suppliers?

CRISPR Therapeutics AG (CRSP) key suppliers include: VERTEX, SIRIUS, Johnson & Johnson, Johnson & Johnson, Metagenomi Therapeutics, Inc. and 3 more. View the full supplier network at chainsifter.com/chain/CRSP.

Who are CRISPR Therapeutics AG's major customers?

CRISPR Therapeutics AG (CRSP) key customers include: VERTEX, Vertex Pharmaceuticals Incorporated, Biodexa Pharmaceuticals Plc, Johnson & Johnson, Johnson & Johnson and 5 more. View the full customer network at chainsifter.com/chain/CRSP.

What sector is CRISPR Therapeutics AG in?

CRISPR Therapeutics AG (CRSP) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

CRSP Supply Chain: CRISPR Therapeutics AG Supplier List & 20 Relationships

8Suppliers

10Customers

2Debt Items

20Related Chains

CRISPR Therapeutics AG Suppliers

Ticker	Name	Confidence	Evidence
VERTEX	VERTEX	90%	Collaboration expense, net, during the three months ended March 31, 2026 and 2025 was net of $ 1.2 million and $ 0.1 million, respectively, of reimbursements from Vertex related to the Vertex Hemoglo…
SIRIUS	SIRIUS	75%	The Company is solely responsible for all research, development, manufacturing and global commercialization activities and associated costs for the siRNA Licensed Products, as well as all associated …
JNJ	Johnson & Johnson	72%	eline. We believe it has the capacity to support, in whole or in part, the manufacture and supply of product for certain of our current clinical programs with the capability to scale-up to support po…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from CRSP graph: eline. We believe it has the capacity to support, in whole or in part, the manufacture and supply of product for certa…
MGX	Metagenomi Therapeutics, Inc.	72%	Reciprocal relationship from MGX graph: amples of any lot of any approved product together with the protocols showing the results of applicable tests at any time. Under some circumstances, the FDA, t…
NKTX	Nkarta, Inc.	72%	Reciprocal relationship from NKTX graph: Item 1A. Risk Factors. An investment in shares of our common stock involves a high degree of risk. You should carefully consider the following risk factors, a…
PRME	Prime Medicine, Inc.	72%	Reciprocal relationship from PRME graph: Reciprocal relationship from CRSP graph: Reciprocal relationship from PRME graph: Reciprocal relationship from CRSP graph: Reciprocal relationship from PRME g…
VRTX	Vertex Pharmaceuticals Incorporated	72%	Reciprocal relationship from VRTX graph: Reciprocal relationship from CRSP graph: Reciprocal relationship from VRTX graph: Reciprocal relationship from CRSP graph: Reciprocal relationship from VRTX g…

CRISPR Therapeutics AG Customers

Ticker	Name	Confidence	Evidence
VERTEX	VERTEX	92%	Pursuant to the 2015 Collaboration Agreement, we agreed to provide technology and options to obtain licenses relating to our CRISPR/Cas technology to Vertex in exchange for a $75.0 million upfront payment.
VRTX	Vertex Pharmaceuticals Incorporated	90%	Reciprocal relationship from VRTX graph: Our current in-license agreements include: • CRISPR Therapeutics AG. In addition to our arrangement with CRISPR described above, we have exercised options to …
BDRX	Biodexa Pharmaceuticals Plc	72%	Reciprocal relationship from BDRX graph: Reciprocal relationship from CRSP graph: Reciprocal relationship from BDRX graph: ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and …
JNJ	Johnson & Johnson	72%	eline. We believe it has the capacity to support, in whole or in part, the manufacture and supply of product for certain of our current clinical programs with the capability to scale-up to support po…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from CRSP graph: eline. We believe it has the capacity to support, in whole or in part, the manufacture and supply of product for certa…
MGX	Metagenomi Therapeutics, Inc.	72%	Reciprocal relationship from MGX graph: Reciprocal relationship from CRSP graph: Reciprocal relationship from MGX graph: amples of any lot of any approved product together with the protocols showing …
NKTX	Nkarta, Inc.	72%	Reciprocal relationship from NKTX graph: Reciprocal relationship from CRSP graph: Reciprocal relationship from NKTX graph: Item 1A. Risk Factors. An investment in shares of our common stock involves …
PRME	Prime Medicine, Inc.	72%	Reciprocal relationship from PRME graph: tic effect in such experiments or studies or they may have other characteristics that may make the product candidates impractical to manufacture, unmarketable…
CVC-GROUP	CVC-GROUP	62%	heir Intellectual Property Rights, The Outcome Of Which Would Be Uncertain And Could Have A Material Adverse Effect On The Success Of Our Business.” The patent prosecution process is expensive, time-…
VILNIUS-UNIVERSITY-TOOLGEN-INC	VILNIUS-UNIVERSITY-TOOLGEN-INC	62%	heir Intellectual Property Rights, The Outcome Of Which Would Be Uncertain And Could Have A Material Adverse Effect On The Success Of Our Business.” The patent prosecution process is expensive, time-…

CRISPR Therapeutics AG Debt Obligations

Instrument	Description	Confidence	Evidence
CRSP-DEBT-8865	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2016-12-31.
CRSP-DEBT	Debt stack $787.6M	90%	Market cache reports total debt of $787.6M.

CRISPR Therapeutics AG Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for CRISPR Therapeutics AG.

CRISPR Therapeutics AG Ownership

Holder	Name	Confidence	Evidence
CRSP-OWNER-ARK-INVESTMENT-MANAGEMENT-LLC	ARK Investment Management LLC	90%	13F overlay lists ARK Investment Management LLC as top holder; 501 tracked holders.

CRISPR Therapeutics AG Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
TWST	Twist Bioscience Corporation	100.00	2
TRDA	Entrada Therapeutics, Inc.	100.00	2
GDTC	CytoMed Therapeutics Limited	100.00	2
COGT	Cogent Biosciences, Inc.	100.00	2
HALO	Halozyme Therapeutics, Inc.	100.00	2
JBIO	Jade Biosciences, Inc.	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2
FDMT	4D Molecular Therapeutics, Inc.	100.00	2
COLL	Collegium Pharmaceutical, Inc.	100.00	2
CRBU	Caribou Biosciences, Inc.	100.00	2
GSK	GSK plc	100.00	2
RXRX	Recursion Pharmaceuticals, Inc.	100.00	2
TPST	Tempest Therapeutics, Inc.	100.00	2
IPSC	Century Therapeutics, Inc.	100.00	2
DTIL	Precision BioSciences, Inc.	100.00	2
CLYM	Climb Bio, Inc.	100.00	2
ALLO	Allogene Therapeutics, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2
EDIT	Editas Medicine, Inc.	100.00	2
ORGO	Organogenesis Holdings Inc.	100.00	2

CRISPR Therapeutics AG Supply Chain